News Summary:
Simulmedia highlighted on September 2, 2026, that for a significant share of prescriptions for older patients, the caregiver, rather than the patient, often decides whether a drug is filled or swapped, impacting go-to-market strategies for certain medications. Previously, on August 23, 2026, the company emphasized television's enduring role as a channel for efficient mass reach, vital for building top-of-funnel brand demand and supporting lower-funnel conversions. Earlier, on August 11, 2026, Simulmedia analyzed the reach limitations of influencer budgets, suggesting that brands would return to TV for Q4 holiday growth, acknowledging that while creators drive trust and conversion, they cannot replicate scaled reach. This followed an analysis published by Simulmedia on July 28, 2026, and reported on August 6, 2026, which found that 89% of comparable returning seasons on Netflix experienced fewer views than their previous seasons, arguing that the streaming service's decision to open ad inventory on The Trade Desk without spend minimums targets a minimally growing audience. On August 3, 2026, the company also released an analysis of branded search as an outcome signal for pharma TV campaigns, examining early performance indicators across 100 advertisers within the US healthcare system.
Subscribe for full access to Simulmedia's profile
Subscribe for full access to Simulmedia's products in full detail 
